Optimus Pharma launched a new Anti-Parkinson’s Drug in India

Hyderabad (Telangana) [India], April 26: Optimus Pharma has announced today that it has received DCGI approval for its Anti-Parkinson’s drug Safinamide. Safinamide is indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing “off” episodes.

The burdens of Parkinson’s Disease (PD) are undeniably serious and increasing while various unmet needs remain, especially the absence of disease-modifying therapies, especially in Indian Market. Optimus believes Safinamide will give an additional option to healthcare professionals in the treatment of Parkinson’s and improve the quality of life of millions who are affected by Parkinson’s disease. A homegrown generic version of Safinamide developed by Optimus will assist in delivering robust treatment for Parkinson’s diseases in India with very high affordability and accessibility.

About Parkinson’s Disease

Parkinson’s disease (PD) is one of the most common neurologic disorders, affecting approximately 1% of individuals older than 60 years and causing progressive disability that can be slowed but not halted, by treatment. Parkinson’s disease is a movement disorder that causes involuntary movements and rigidity, as well as abnormal walking and posture. It is caused by an imbalance between two chemicals that transmit signals from the brain, dopamine, and acetylcholine.

Disclaimer:

Statements in this “Document” describing the Company’s objectives, projections, estimates, expectations, plans or predictions, or industry conditions or events may be “forward-looking statements” within the meaning of applicable securities laws and regulations. Actual results, performance, or achievements could differ materially from those expressed or implied. The Company undertakes no obligation to update or revise forward-looking statements to reflect developments or circumstances that arise or to reflect the occurrence of unanticipated developments/circumstances after the date hereof.

Business

Arjun Rampal Joins FunExch as Brand Ambassador, Pledging Responsible Gaming

Mumbai (Maharashtra) [India], September 18: FunExch is a leading online gaming platform that provides a safe and responsible environment for users to enjoy their favourite sports and games. With a commitment to responsible gaming, FunExch offers a wide array of sports options and entertainment experiences, making it a popular choice among gaming enthusiasts worldwide. FunExch, […]

Read More
Business

Unlocking Business Excellence: Highlights from the 2023 Business Automation Summit in Gurgaon

Gurugram (Haryana) [India], September 19: The highly anticipated Business Automation Summit took place on September 15th and 16th at the Lemon Tree in sector 60, Gurgaon. The event proved to be a pivotal gathering for industry leaders, entrepreneurs, and professionals who delved into the latest advancements in Business Automation & WhatsApp Tools and Systems. Keynote […]

Read More
Business

TECNO forays into Laptop Category with the Launch of MEGABOOK T1: An Ultimate Fusion of Power and Elegance

Awarded at the German Red Dot Awards for its standout design, the MEGABOOK T1 is up for an Early Bird sale on Amazon New Delhi (India), September 14: TECNO, a global leader in cutting-edge technology and innovation, is thrilled to announce the debut of the MEGABOOK T1, a trailblazing entry into India’s AIoT ecosystem. With its […]

Read More